Clinical Trials Directory

Trials / Unknown

UnknownNCT03367052

Clinical and Radiological Outcomes: Two-level Cervical ProDisc-C Vivo Versus Hybrid Construct.

Clinical and Radiological Outcomes of a 7-year Follow-up, Multi-center, Prospective, Randomized, Controlled Trial: Two-level Cervical ProDisc-C Vivo Versus Hybrid Construct.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
542 (estimated)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to investigate the clinical and radiological results of two-level cervical ProDisc-C vivo versus hybrid construct.

Detailed description

This is a prospective, randomized, multicenter trial at 7 years of follow-up comparing two level ProDisc-C vivo artificial cervical disc replacement and hybrid construct, i.e., combining ACDF (Anterior cervical discectomy fusion) and ProDisc-C vivo to treat degenerative disc disease (DDD). 542 DDD patients (age from 20 to 70) from several hospitals matching the inclusion criteria will be randomly assigned to two groups (271 patients in each group). One group will be treated with two level ProDisc-C vivo disc replacement. The other group will be treated with hybrid construct. Clinical outcomes and radiological analysis will be done at 1.5, 3, 6, 12, 24, 36, 60, and 84 months after the surgical treatments.

Conditions

Interventions

TypeNameDescription
PROCEDURETwo level Prodisc-C vivoTwo level of Prodisc-C vivo artificial disc replacement will be done in one group of patients.
PROCEDUREHybridThe hybrid method will be used in one group of patients.

Timeline

Start date
2018-01-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2017-12-08
Last updated
2017-12-08

Source: ClinicalTrials.gov record NCT03367052. Inclusion in this directory is not an endorsement.